PolyNovo Limited (ASX:PNV)
Australia · Delayed Price · Currency is AUD 1.285
+0.025 (1.98%)
At close: Dec 24, 2025
PolyNovo Market Cap
PolyNovo has a market cap or net worth of 887.73 million as of December 26, 2025. Its market cap has decreased by -39.39% in one year.
Market Cap
887.73M
Enterprise Value
871.28M
Revenue
128.70M
Ranking
n/a
PE Ratio
67.99
Stock Price
1.29
Market Cap Chart
Since August 23, 1999, PolyNovo's market cap has increased from 33.09M to 887.73M, an increase of 2,583.02%. That is a compound annual growth rate of 13.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 887.73M | -37.01% |
| Dec 31, 2024 | 1.41B | 23.37% |
| Dec 29, 2023 | 1.14B | -17.80% |
| Dec 30, 2022 | 1.39B | 37.79% |
| Dec 31, 2021 | 1.01B | -60.68% |
| Dec 31, 2020 | 2.57B | 96.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 82.72B |
| Pro Medicus | 23.58B |
| Cochlear | 17.13B |
| Sonic Healthcare | 11.15B |
| Ramsay Health Care | 8.09B |
| Ansell | 5.05B |
| Telix Pharmaceuticals | 4.03B |
| Mesoblast | 3.72B |